Should Blood Cultures Be Drawn Through an Indwelling Catheter?
bacteremia
blood culture
bloodstream infection
catheter infection
central line associated bloodstream infection
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
received:
09
11
2023
accepted:
30
04
2024
medline:
21
5
2024
pubmed:
21
5
2024
entrez:
21
5
2024
Statut:
epublish
Résumé
There is no practical way to definitively diagnose a catheter-related bloodstream infection in situ if blood cultures are only obtained percutaneously unless there is the rare occurrence of purulent drainage from a central venous catheter insertion site. That is why the Infectious Diseases Society of America guidelines for diagnosis and management of catheter-related bloodstream infections and Infectious Diseases Society of America guidelines for evaluation of fever in critically ill patients both recommend drawing blood cultures from a central venous catheter and percutaneously if the catheter is a suspected source of infection. However, central venous catheter-drawn blood cultures may be more likely to be positive reflecting catheter hub, connector, or intraluminal colonization, and many hospitals in the United States discourage blood culture collection from catheters in an effort to reduce reporting of central-line associated bloodstream infections to the Centers for Disease Control and Prevention. As such, clinical decisions are made regarding catheter removal or other therapeutic interventions based on incomplete and potentially inaccurate data. We urge clinicians to obtain catheter-drawn blood cultures when the catheter may be the source of suspected infection.
Identifiants
pubmed: 38770214
doi: 10.1093/ofid/ofae248
pii: ofae248
pmc: PMC11103617
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofae248Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Déclaration de conflit d'intérêts
Potential conflicts of interest. Dr. Mermel is on the Scientific Advisory Board of Citius Pharma and serves as a consultant for CorMedix. Dr. Rupp has received research funding from Magnolia Medical Technologies, Contrafect, and NIH/Duke Clinical Research Institute and has served as a consultant or on an advisory board for Citius Pharmaceuticals, 3M, and Teleflex.